CoChat

Efficacy and Limitations of Chemically Diverse Small-Molecule Enzyme-Inhibitors against the Synergistic Coagulotoxic Activities of Bitis Viper Venoms

Youngman, Nicholas J., Lewin, Matthew R., Carter, Rebecca, Naude, Arno, Fry, Bryan G. · 2022 · Molecules
Cited by 22

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Snakebite remains a significant public health burden globally, disproportionately affecting low-income and impoverished regions of the world. Recently, researchers have begun to focus on the use of small-molecule inhibitors as potential candidates for the neutralisation of key snake venom toxins and as potential field therapies. Bitis vipers represent some of the most medically important as well as frequently encountered snake species in Africa, with a number of species possessing anticoagulant phospholipase A2 (PLA2) toxins that prevent the prothrombinase complex from inducing clot formation. Additionally, species within the genus are known to exert pseudo-procoagulant activity, whereby kallikrein enzymatic toxins cleave fibrinogen to form a weak fibrin clot that rapidly degrades, thereby depleting fibrinogen levels and contributing to the net anticoagulant state. Utilising well-validated coagulation assays measuring time until clot formation, this study addresses the in vitro efficacy of three small molecule enzyme inhibitors (marimastat, prinomastat and varespladib) in neutralising these aforementioned activities. The PLA2 inhibitor varespladib showed the greatest efficacy for the neutralisation of PLA2-driven anticoagulant venom activity, with the metalloproteinase inhibitors prinomastat and marimastat both showing low and highly variable degrees of cross-neutralisation with PLA2 anticoagulant toxicity. However, none of the inhibitors showed efficacy in neutralising the pseudo-procoagulant venom activity exerted by the venom of B. caudalis. Our results highlight the complex nature of snake venoms, for which single-compound treatments will not be universally effective, but combinations might prove highly effective. Despite the limitations of these inhibitors with regards to in vitro kallikrein enzyme pseudo-procoagulant venom activity, our results further support the growing body of literature indicating the potential use of small molecule inhibitors to enhance first-aid treatment of snakebite envenoming, particularly in cases where hospital and thus antivenom treatment is either unavailable or far away.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules27051733

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 33

  1. Fry, B. (2018). Snakebite: When the human touch becomes a bad touch. Toxins, 10. · DOI
  2. Calvete, 2017, Snakebite envenoming, Nat. Rev. Dis. Primers, 3, 17063, 10.1038/nrdp.2017.63 · DOI · Paper page
  3. Kasturiratne, A., Wickremasinghe, A.R., de Silva, N., Gunawardena, N.K., Pathmeswaran, A., Premaratna, R., Savioli, L., Lalloo, D.G., and de Silva, H.J. (2008). The global burden of snakebite: A literature analysis and modelling based on regional estimates of envenoming and deaths (Global Burden of Snakebite). PLoS Med., 5. · DOI · Paper page
  4. Williams, D.J., Faiz, M.A., Abela-Ridder, B., Ainsworth, S., Bulfone, T.C., Nickerson, A.D., Habib, A.G., Junghanss, T., Fan, H.W., and Turner, M. (2019). Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl. Trop. Dis., 13. · DOI · Paper page
  5. Fernandez, S., Hodgson, W., Chaisakul, J., Kornhauser, R., Konstantakopoulos, N., Smith, A.I., and Kuruppu, S. (2014). In vitro toxic effects of puff adder (Bitis arietans) venom, and their neutralization by antivenom. Toxins, 6. · doi:10.3390/toxins6051586
  6. Lavonas, 2002, Severe puff adder (Bitis arietans) envenomation with coagulopathy, Clin. Toxicol., 40, 911
  7. Janette, 2016, The effect of physiological levels of South African puff adder (Bitis arietans) snake venom on blood cells: An in vitro model, Sci. Rep., 6, 35988, 10.1038/srep35988 · doi:10.1038/srep35988
  8. Paixão-Cavalcante, D., Kuniyoshi, A.K., Portaro FC, V., da Silva, W.D., and Tambourgi, D.V. (2015). African adders: Partial characterization of snake venoms from three Bitis species of medical importance and their neutralization by experimental equine antivenoms (Characterization of Bitis spp snake venoms). PLoS Negl. Trop. Dis., 9. · DOI
  9. Spawls, S., and Branch, B. (2020). The Dangerous Snakes of Africa, Bloomsbury Publishing.
  10. Modler, 2012, Snake bite in southern Africa: Diagnosis and management, Contin. Med. Educ., 30, 362
  11. Quental, 2016, Diversification in vipers: Phylogenetic relationships, time of divergence and shifts in speciation rates, Mol. Phylogenetics Evol., 105, 50, 10.1016/j.ympev.2016.07.029 · DOI · Paper page
  12. Barlow, 2019, Ancient habitat shifts and organismal diversification are decoupled in the African viper genus Bitis (Serpentes: Viperidae), J. Biogeogr., 46, 1234, 10.1111/jbi.13578 · DOI
  13. Youngman, N.J., Debono, J., Dobson, J.S., Zdenek, C.N., Harris, R.J., Brouw, B.O.D., Coimbra, F.C.P., Naude, A., Coster, K., and Sundman, E. (2019). Venomous landmines: Clinical implications of extreme coagulotoxic diversification and differential neutralization by antivenom of venoms within the Viperid snake genus Bitis. Toxins, 11. · doi:10.3390/toxins11070422
  14. Bulfone, 2018, Developing Small Molecule Therapeutics for the Initial and Adjunctive Treatment of Snakebite.(Medical condition overview), J. Trop. Med., 2018, 4320175, 10.1155/2018/4320175 · DOI · Paper page
  15. Albulescu, 2020, A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite, Nat. Commun., 11, 6094, 10.1038/s41467-020-19981-6 · DOI · Paper page
  16. Lewin, M., Samuel, S., Merkel, J., and Bickler, P. (2016). Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation. Toxins, 8. · DOI · Paper page
  17. Bittenbinder, M.A., Zdenek, C.N., Op Den Brouw, B., Youngman, N.J., Dobson, J.S., Naude, A., Vonk, F.J., and Fry, B.G. (2018). Coagulotoxic cobras: Clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (Varespladib). Toxins, 10. · DOI · Paper page
  18. Lewin, 2016, Varespladib (LY315920) appears to be a very potent, broad-spectrum, inhibitor of snake venom PLA2s from six continents, Toxicon, 117, 103, 10.1016/j.toxicon.2016.04.006 · DOI
  19. Wang, Y., Zhang, J., Zhang, D., Xiao, H., Xiong, S., and Huang, C. (2018). Exploration of the inhibitory potential of varespladib for snakebite envenomation. Molecules, 23. · DOI · Paper page
  20. Zdenek, 2020, Anticoagulant toxicity of black snake (Elapidae: Pseudechis) venoms: Potency, mechanisms, and antivenom efficacy, Toxicol. Lett., 330, 176, 10.1016/j.toxlet.2020.05.014 · DOI
  21. Youngman, 2020, Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms, Comp. Biochem. Physiol. Toxicol. Pharmacol., 236, 108818, 10.1016/j.cbpc.2020.108818 · DOI
  22. Chowdhury, 2021, The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms, Front. Immunol., 12, 4215, 10.3389/fimmu.2021.752442 · DOI · Paper page
  23. Chowdhury, 2021, Clinical implications of differential procoagulant toxicity of the Palearctic viperid genus Macrovipera, and the relative neutralization efficacy of antivenoms and enzyme inhibitors, Toxicol. Lett., 340, 77, 10.1016/j.toxlet.2020.12.019 · DOI
  24. Marsh, 1974, Separation and partial characterization of a coagulant enzyme from Bitis gabonica venom, Br. J. Haematol., 26, 295, 10.1111/j.1365-2141.1974.tb00474.x · doi:10.1111/j.1365-2141.1974.tb00474.x
  25. Pirkle, 1986, Thrombin-like enzyme from the venom of Bitis gabonica. Purification, properties, and coagulant actions, J. Biol. Chem., 261, 8830, 10.1016/S0021-9258(19)84456-3 · doi:10.1016/s0021-9258(19)84456-3
  26. Vaiyapuri, S., Harrison, R.A., Bicknell, A.B., Gibbins, J.M., and Hutchinson, G. (2010). Purification and functional characterisation of Rhinocerase, a novel serine protease from the venom of Bitis gabonica rhinoceros (Rhinocerase–A venom enzyme). PLoS ONE, 5. · doi:10.1371/journal.pone.0009687
  27. Viljoen, 1979, Separation of Bitis gabonica (Gaboon adder) venom arginine esterases into kinin-releasing, clotting and fibrinolytic factors, Toxicon, 17, 145, 10.1016/0041-0101(79)90293-9 · doi:10.1016/0041-0101(79)90293-9
  28. Bourke, 2020, Trimeresurus albolabris snakebite treatment implications arising from ontogenetic venom comparisons of anticoagulant function, and antivenom efficacy, Toxicol. Lett., 327, 2, 10.1016/j.toxlet.2020.03.009 · DOI
  29. Debono, 2019, Habu coagulotoxicity: Clinical implications of the functional diversification of Protobothrops snake venoms upon blood clotting factors, Toxicol. Vitr., 55, 62, 10.1016/j.tiv.2018.11.008 · DOI
  30. Seneci, 2021, A symphony of destruction: Dynamic differential fibrinogenolytic toxicity by rattlesnake (Crotalus and Sistrurus) venoms, Comp. Biochem. Physiol. Part C Toxicol. Pharmacol., 245, 109034, 10.1016/j.cbpc.2021.109034 · DOI
  31. Xie, C., Albulescu, L.-O., Bittenbinder, M.A., Somsen, G.W., Vonk, F.J., Casewell, N.R., and Kool, J. (2020). Neutralizing effects of small molecule inhibitors and metal chelators on coagulopathic viperinae snake venom toxins. Biomedicines, 8. · doi:10.1101/2020.06.02.129643
  32. Abubakar, 2010, Amputation and disability following snakebite in Nigeria, Trop. Dr., 40, 114
  33. Sharma, 2004, Impact of snake bites and determinants of fatal outcomes in southeastern Nepal, Am. J. Trop. Med. Hyg., 71, 234, 10.4269/ajtmh.2004.71.234 · doi:10.4269/ajtmh.2004.71.234

Cited by

See all 22

Metadata

Authors
Youngman, N. J., Lewin, M. R., Carter, R., Naude, A., & Fry, B. G.
Affiliations
  • Venom Evolution Lab, School of Biological Science, University of Queensland, St. Lucia, QLD 4072, Australia
  • California Academy of Sciences, San Francisco, CA 94118, USA
  • Ophirex Inc., Corte Madera, CA 94925, USA
  • Snakebite Assist, Pretoria ZA-0001, South Africa
Venue
Molecules
Publisher
MDPI AG
Published
2022-03-07
Volume
27
Issue
5
Pages
1733
ISSN
1420-3049
Cited by
22
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Limitations of Chemically Diverse Small-Molecule Enzyme-Inhibitors against the Synergistic Coagulotoxic Activities of Bitis Viper Venoms. https://app.cochat.ai/papers/10.3390/molecules27051733
The paper
Youngman, N. J., Lewin, M. R., Carter, R., Naude, A., & Fry, B. G. (2022). Efficacy and Limitations of Chemically Diverse Small-Molecule Enzyme-Inhibitors against the Synergistic Coagulotoxic Activities of Bitis Viper Venoms. Molecules. https://doi.org/10.3390/molecules27051733

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.